Atlas Trials

Fuzheng Huayu Tablets Reduce the Occurrence of Re-Decompensation Events in Patients With First Decompensation of Hepatitis B-Related Liver Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

Clinical trial NCT07017426 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07017426
Sponsor
Zhiyun Yang
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Decompensated Hepatitis B Cirrhosis
Start date
2025-07-01
Primary completion
2027-07-01
Enrollment
432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.